Evidence map›Paper›PMID 29555602›Full record

ArticlePapillomavirus research (Amsterdam, Netherlands)2018

Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases.

Maria Alejo, Laia Alemany, Omar Clavero, Beatriz Quiros, Susana Vighi, Muhieddine Seoud, Chou Cheng-Yang, Suzanne M Garland, Nuria Juanpere, Josep Lloreta and 7 more

Abstract read
In one paragraph

Article in Papillomavirus research (Amsterdam, Netherlands), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Journal of gynecologic oncology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Maria AlejoHospital General de l'Hospitalet, Consorci Sanitari Integral, L'Hospitalet de Llobregat, Barcelona, Spain.
Laia AlemanyInfections and Cancer Unit, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia (ICO)-IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERESP), Madrid, Spain.
Omar ClaveroInfections and Cancer Unit, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia (ICO)-IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Electronic address: oclavero@iconcologia.net.
Beatriz QuirosInfections and Cancer Unit, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia (ICO)-IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Susana VighiHospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina.
Muhieddine SeoudThe American University of Beirut Medical Center, Beirut, Lebanon.
Chou Cheng-YangNational Cheng Kung University Medical College, Taiwan Association of Gynecologic Oncologists, Tainan, Taiwan.
Suzanne M GarlandThe Royal Women's Hospital, The University of Melbourne, Melbourne, Australia.
Nuria JuanpereHospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Josep LloretaHospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Sara TousInfections and Cancer Unit, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia (ICO)-IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Jo Ellen KlaustermeierInfections and Cancer Unit, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia (ICO)-IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain.
Wim QuintDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
F Xavier BoschInfections and Cancer Unit, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia (ICO)-IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Silvia de SanjoséInfections and Cancer Unit, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia (ICO)-IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERESP), Madrid, Spain.
Belen LloverasHospital del Mar, Parc de Salut Mar, Barcelona, Spain.
RIS HPV TT study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsNeuroendocrine tumors (NET) of the cervix are rare tumors with a very aggressive course. The human papillomavirus (HPV) has been linked to its etiology. The objective of this study is to describe HPV prevalence and genotype distribution of NET. METHODS AND

resultsForty-nine tumors with histological neuroendocrine features were identified among 10,575 invasive cervical cancer (ICC) cases from an international study. HPV DNA detection was done using SPF10/DEIA /LiPA

conclusionsOur data confirms the association of cervical NET with HPV and p16

Indexed as

AdultAgedCyclin-Dependent Kinase Inhibitor p16DNA, ViralFemaleGenotypeHuman papillomavirus 16Human papillomavirus 18HumansImmunohistochemistryMicroscopy, ElectronMiddle AgedNeoplasm InvasivenessNeuroendocrine TumorsPapillomaviridaePapillomavirus InfectionsCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16DNA, ViralCervical CancerHuman PapillomavirusImmunohistochemistryNeuroendocrine TumorPCR

Identifiers

PMID29555602
PMCPMC5909066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.